Join us for a presentation reviewing key issues and considerations investors in Asia should keep in mind when investing in startup companies in the US life sciences industry.
|
|
We will discuss due diligence areas in the life sciences industry and the use of side letters when negotiating specific business terms when making the investment.
|
|
Key topics and issues relevant to cross-border investments in the US life sciences space will also be covered, including certain venture investment terms and foreign direct investment regulations in the US administered by the Committee on Foreign Investment in the United States, which increasingly reviews investments by non-US companies of early-stage US technology companies. |
|
View the full series > |
|
Asia Life Sciences is a series of tailored webinars led by a cross-practice team of Morgan Lewis life sciences lawyers. The program focuses on hot topics, trends, and key developments in the life sciences industry essential to our clients and contacts operating in Asia. This series includes bilingual sessions where we explore regional developments and updates. |
|
|
|